![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism 39th European Workshop for Rheumatology Research, 28 Februaryâ2 March 2019, Lyon, France - ()] Abstracts - P148â JAK-inhibition by baricitinib and tofacitinib ameliorates pathological bone loss
Adam, S, Simon, N, Steffen, U, Andes, F, Müller, D, Culemann, S, Andreev, D, Hahn, M, Scholtysek, C, Schett, G, Krönke, G, Frey, S, Hueber, AYear:
2019
DOI:
10.1136/annrheumdis-2018-ewrr2019.131
File:
PDF, 65 KB
2019